Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Ensuring Sound Bioanalytical Methods Transfer

February 1, 2014
Pharmaceutical Technology

For a drug-development process that relies on outsourced services, special considerations are needed to ensure the proper transfer of technology and information from one phase to the next.

Will CMOs Provide Sufficient Capacity for Growing Biologics Demand

January 31, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.

R&D in Transition

January 2, 2014

Pharmaceutical Technology

The R&D model is in transition and creating new demands on contract services providers.

Drug Manufacturing Focus: Why India?

December 2, 2013

Pharmaceutical Technology

Siegfried Schmitt, principal consultant at PAREXEL, discusses the state of drug manufacturing in India.

Climate Change in Outsourcing

December 2, 2013

Pharmaceutical Technology

Ongoing changes create new opportunities for CROs and CMOs.

Disposable Applications in Demand by Biopharma

November 2, 2013

Pharmaceutical Technology

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

The Expense of Vision in Outsourcing

October 2, 2013

Pharmaceutical Technology

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Changing the Dynamic of CROs

October 2, 2013

Pharmaceutical Technology

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

CROs Face Issues with Talent Retention

September 4, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

A recent survey shows that talent retention is an issue on industry level for contract research organizations (CROs), particularly for CROs located outside the United States.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here